Source: Transactions of the Royal Society of Tropical Medicine and Hygiene. Unidade: FM
Subjects: ANTIFÚNGICOS, LEISHMANIOSE CUTÂNEA (TERAPIA), AVES
ABNT
ROCIO, Carolina et al. Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients. Transactions of the Royal Society of Tropical Medicine and Hygiene, v. 108, n. 3, p. 176-178, 2014Tradução . . Disponível em: https://doi.org/10.1093/trstmh/tru011. Acesso em: 30 abr. 2024.APA
Rocio, C., Amato, V. S., Camargo, R. A., & Tuon, F. F. (2014). Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients. Transactions of the Royal Society of Tropical Medicine and Hygiene, 108( 3), 176-178. doi:10.1093/trstmh/tru011NLM
Rocio C, Amato VS, Camargo RA, Tuon FF. Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients [Internet]. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2014 ; 108( 3): 176-178.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1093/trstmh/tru011Vancouver
Rocio C, Amato VS, Camargo RA, Tuon FF. Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients [Internet]. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2014 ; 108( 3): 176-178.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1093/trstmh/tru011